Task: Answer the multiple choice question.
Query: Which drug exhibits a 4.194\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a O=C(c1ccc(Cn2cnnn2)cc1)N1CCCC(Nc2ccc(F)cc2)C1
b COC(=O)/C(=C\c1cccnc1)NC(=O)c1ccc(OCc2ccccc2)cc1
c Cc1ccc(N(CC(=O)N2CCc3ccccc32)S(=O)(=O)c2cccs2)cc1
Answer: b. COC(=O)/C(=C\c1cccnc1)NC(=O)c1ccc(OCc2ccccc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)/C(=C\c1cccnc1)NC(=O)c1ccc(OCc2ccccc2)cc1
COC(=O)/C(=C\c1cccnc1)NC(=O)c1ccc(OCc2ccccc2)cc1
methyl (E)-2-[(4-phenylmethoxybenzoyl)amino]-3-pyridin-3-ylprop-2-enoate